Israel and US-based exoskeleton producer ReWalk Robotics has updated the terms for its forthcoming IPO.
The company, which initially filed for an IPO in July, plans to raise between $46.9 and $53.6m by offering 3.4 million shares at a price range of $14 to $16 per share.
ReWalk, which was until recently known as Argo Medical Technologies, plans to offer the IPO in the second week of September.
Barclays Capital and Jefferies will serve as underwriters for the deal.
Founded in 2001, ReWalk produces motorized legs that can help individuals with spinal chord injuries walk.
Rewalk’s shareholders include motor technology producer Yaskawa Electric, which owns 25.4% after investing $17m in September 2013.
Other large shareholders are venture capital firms SCP Vitalife Partners, which is Rewalk’s biggest shareholder with a 28.4% stake, Israel Healthcare Ventures, Pontifax and Previz Ventures.